Disruption of Ceruloplasmin and Hephaestin in Mice Causes Retinal Iron Overload and Retinal Degeneration with Features of Age-Related Macular Degeneration
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Iron Transport Proteins: Gateways of Cellular and Systemic Iron Homeostasis
Iron transport proteins: Gateways of cellular and systemic iron homeostasis Mitchell D. Knutson, PhD University of Florida Essential Vocabulary Fe Heme Membrane Transport DMT1 FLVCR Ferroportin HRG1 Mitoferrin Nramp1 ZIP14 Serum Transport Transferrin Transferrin receptor 1 Cytosolic Transport PCBP1, PCBP2 Timeline of identification in mammalian iron transport Year Protein Original Publications 1947 Transferrin Laurell and Ingelman, Acta Chem Scand 1959 Transferrin receptor 1 Jandl et al., J Clin Invest 1997 DMT1 Gunshin et al., Nature; Fleming et al. Nature Genet. 1999 Nramp1 Barton et al., J Leukocyt Biol 2000 Ferroportin Donovan et al., Nature; McKie et al., Cell; Abboud et al. J. Biol Chem 2004 FLVCR Quigley et al., Cell 2006 Mitoferrin Shaw et al., Nature 2006 ZIP14 Liuzzi et al., Proc Natl Acad Sci USA 2008 PCBP1, PCBP2 Shi et al., Science 2013 HRG1 White et al., Cell Metab DMT1 (SLC11A2) • Divalent metal-ion transporter-1 • Former names: Nramp2, DCT1 Fleming et al. Nat Genet, 1997; Gunshin et al., Nature 1997 • Mediates uptake of Fe2+, Mn2+, Cd2+ • H+ coupled transporter (cotransporter, symporter) • Main roles: • intestinal iron absorption Illing et al. JBC, 2012 • iron assimilation by erythroid cells DMT1 (SLC11A2) Yanatori et al. BMC Cell Biology 2010 • 4 different isoforms: 557 – 590 a.a. (hDMT1) Hubert & Hentze, PNAS, 2002 • Function similarly in iron transport • Differ in tissue/subcellular distribution and regulation • Regulated by iron: transcriptionally (via HIF2α) post-transcriptionally (via IRE) IRE = Iron-Responsive Element Enterocyte Lumen DMT1 Fe2+ Fe2+ Portal blood Enterocyte Lumen DMT1 Fe2+ Fe2+ Fe2+ Fe2+ Ferroportin Portal blood Ferroportin (SLC40A1) • Only known mammalian iron exporter Donovan et al., Nature 2000; McKie et al., Cell 2000; Abboud et al. -
Ferroportin Mutation in Autosomal Dominant Hemochromatosis: Loss of Function, Gain in Understanding
Ferroportin mutation in autosomal dominant hemochromatosis: loss of function, gain in understanding Robert E. Fleming, William S. Sly J Clin Invest. 2001;108(4):521-522. https://doi.org/10.1172/JCI13739. Commentary Normal iron homeostasis requires close matching of dietary iron absorption with body iron needs (1). Hereditary hemochromatosis (HH), a common abnormality of iron metabolism, is characterized by excess absorption of dietary iron despite elevated stores, and secondary damage to the liver, pancreas, and other organs (2). Classic HH is caused by mutation of the HFE gene and is inherited as an autosomal recessive trait. However, a substantial percentage of individuals with hemochromatosis, especially in non–Northern European populations, have no mutations in HFE (3). Many such cases differ from classic HH in the relative distribution of iron between the plasma, hepatocytes, and reticuloendothelial (RE) cells (4). Pietrangelo et al. recently reported a pedigree with atypical hemochromatosis inherited as an autosomal dominant trait (5). In this issue of the JCI, Montosi et al. report the surprising finding that the gene mutated in these patients (SLC11A3) encodes the iron export protein ferroportin1 (also known as IREG1, or MTP1) (6). They conclude that the identified mutation (A77D) probably results in loss of ferroportin1 function, suggesting that the affected individuals are haploinsufficient for this gene product. In a nearly simultaneous report, Njajou et al. (7) describe a similar pedigree with autosomal dominant hemochromatosis and a different missense mutation (N144H) in the same gene. Njajou et al., however, conclude that the iron overload phenotype was likely […] Find the latest version: https://jci.me/13739/pdf Ferroportin mutation in autosomal Commentary dominant hemochromatosis: loss See related article, pages 619–623. -
Hyperplasia (Growth Factors
Adaptations Robbins Basic Pathology Robbins Basic Pathology Robbins Basic Pathology Coagulation Robbins Basic Pathology Robbins Basic Pathology Homeostasis • Maintenance of a steady state Adaptations • Reversible functional and structural responses to physiologic stress and some pathogenic stimuli • New altered “steady state” is achieved Adaptive responses • Hypertrophy • Altered demand (muscle . hyper = above, more activity) . trophe = nourishment, food • Altered stimulation • Hyperplasia (growth factors, . plastein = (v.) to form, to shape; hormones) (n.) growth, development • Altered nutrition • Dysplasia (including gas exchange) . dys = bad or disordered • Metaplasia . meta = change or beyond • Hypoplasia . hypo = below, less • Atrophy, Aplasia, Agenesis . a = without . nourishment, form, begining Robbins Basic Pathology Cell death, the end result of progressive cell injury, is one of the most crucial events in the evolution of disease in any tissue or organ. It results from diverse causes, including ischemia (reduced blood flow), infection, and toxins. Cell death is also a normal and essential process in embryogenesis, the development of organs, and the maintenance of homeostasis. Two principal pathways of cell death, necrosis and apoptosis. Nutrient deprivation triggers an adaptive cellular response called autophagy that may also culminate in cell death. Adaptations • Hypertrophy • Hyperplasia • Atrophy • Metaplasia HYPERTROPHY Hypertrophy refers to an increase in the size of cells, resulting in an increase in the size of the organ No new cells, just larger cells. The increased size of the cells is due to the synthesis of more structural components of the cells usually proteins. Cells capable of division may respond to stress by undergoing both hyperrtophy and hyperplasia Non-dividing cell increased tissue mass is due to hypertrophy. -
Supplementary Table S4. FGA Co-Expressed Gene List in LUAD
Supplementary Table S4. FGA co-expressed gene list in LUAD tumors Symbol R Locus Description FGG 0.919 4q28 fibrinogen gamma chain FGL1 0.635 8p22 fibrinogen-like 1 SLC7A2 0.536 8p22 solute carrier family 7 (cationic amino acid transporter, y+ system), member 2 DUSP4 0.521 8p12-p11 dual specificity phosphatase 4 HAL 0.51 12q22-q24.1histidine ammonia-lyase PDE4D 0.499 5q12 phosphodiesterase 4D, cAMP-specific FURIN 0.497 15q26.1 furin (paired basic amino acid cleaving enzyme) CPS1 0.49 2q35 carbamoyl-phosphate synthase 1, mitochondrial TESC 0.478 12q24.22 tescalcin INHA 0.465 2q35 inhibin, alpha S100P 0.461 4p16 S100 calcium binding protein P VPS37A 0.447 8p22 vacuolar protein sorting 37 homolog A (S. cerevisiae) SLC16A14 0.447 2q36.3 solute carrier family 16, member 14 PPARGC1A 0.443 4p15.1 peroxisome proliferator-activated receptor gamma, coactivator 1 alpha SIK1 0.435 21q22.3 salt-inducible kinase 1 IRS2 0.434 13q34 insulin receptor substrate 2 RND1 0.433 12q12 Rho family GTPase 1 HGD 0.433 3q13.33 homogentisate 1,2-dioxygenase PTP4A1 0.432 6q12 protein tyrosine phosphatase type IVA, member 1 C8orf4 0.428 8p11.2 chromosome 8 open reading frame 4 DDC 0.427 7p12.2 dopa decarboxylase (aromatic L-amino acid decarboxylase) TACC2 0.427 10q26 transforming, acidic coiled-coil containing protein 2 MUC13 0.422 3q21.2 mucin 13, cell surface associated C5 0.412 9q33-q34 complement component 5 NR4A2 0.412 2q22-q23 nuclear receptor subfamily 4, group A, member 2 EYS 0.411 6q12 eyes shut homolog (Drosophila) GPX2 0.406 14q24.1 glutathione peroxidase -
Identification of Potential Key Genes and Pathway Linked with Sporadic Creutzfeldt-Jakob Disease Based on Integrated Bioinformatics Analyses
medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Identification of potential key genes and pathway linked with sporadic Creutzfeldt-Jakob disease based on integrated bioinformatics analyses Basavaraj Vastrad1, Chanabasayya Vastrad*2 , Iranna Kotturshetti 1. Department of Biochemistry, Basaveshwar College of Pharmacy, Gadag, Karnataka 582103, India. 2. Biostatistics and Bioinformatics, Chanabasava Nilaya, Bharthinagar, Dharwad 580001, Karanataka, India. 3. Department of Ayurveda, Rajiv Gandhi Education Society`s Ayurvedic Medical College, Ron, Karnataka 562209, India. * Chanabasayya Vastrad [email protected] Ph: +919480073398 Chanabasava Nilaya, Bharthinagar, Dharwad 580001 , Karanataka, India NOTE: This preprint reports new research that has not been certified by peer review and should not be used to guide clinical practice. medRxiv preprint doi: https://doi.org/10.1101/2020.12.21.20248688; this version posted December 24, 2020. The copyright holder for this preprint (which was not certified by peer review) is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission. Abstract Sporadic Creutzfeldt-Jakob disease (sCJD) is neurodegenerative disease also called prion disease linked with poor prognosis. The aim of the current study was to illuminate the underlying molecular mechanisms of sCJD. The mRNA microarray dataset GSE124571 was downloaded from the Gene Expression Omnibus database. Differentially expressed genes (DEGs) were screened. -
Acquired Tumors Arising from Congenital Hypertrophy of the Retinal Pigment Epithelium
CLINICAL SCIENCES Acquired Tumors Arising From Congenital Hypertrophy of the Retinal Pigment Epithelium Jerry A. Shields, MD; Carol L. Shields, MD; Arun D. Singh, MD Background: Congenital hypertrophy of the retinal lacunae in all 5 patients. The CHRPE ranged in basal di- pigment epithelium (CHRPE) is widely recognized to ameter from 333mmto13311 mm. The size of the el- be a flat, stationary condition. Although it can show evated lesion ranged from 23232mmto83834 mm. minimal increase in diameter, it has not been known to The nodular component in all cases was supplied and spawn nodular tumor that is evident ophthalmoscopi- drained by slightly prominent, nontortuous retinal blood cally. vessels. Yellow retinal exudation occurred adjacent to the nodule in all 5 patients and 1 patient developed a second- Objectives: To report 5 cases of CHRPE that gave rise ary retinal detachment. Two tumors that showed progres- to an elevated lesion and to describe the clinical features sive enlargement, increasing exudation, and progressive of these unusual nodules. visual loss were treated with iodine 125–labeled plaque brachytherapy, resulting in deceased tumor size but no im- Methods: Retrospective medical record review. provement in the visual acuity. Results: Of 5 patients with a nodular lesion arising from Conclusions: Congenital hypertrophy of the retinal pig- CHRPE, there were 4 women and 1 man, 4 whites and 1 ment epithelium can spawn a nodular growth that slowly black. Three patients were followed up for typical CHRPE enlarges, attains a retinal blood supply, and causes exuda- for longer than 10 years before the tumor developed; 2 pa- tiveretinopathyandchroniccystoidmacularedema.Although tients were recognized to have CHRPE and the elevated no histopathologic evidence is yet available, we believe that tumor concurrently. -
Chapter 1 Cellular Reaction to Injury 3
Schneider_CH01-001-016.qxd 5/1/08 10:52 AM Page 1 chapter Cellular Reaction 1 to Injury I. ADAPTATION TO ENVIRONMENTAL STRESS A. Hypertrophy 1. Hypertrophy is an increase in the size of an organ or tissue due to an increase in the size of cells. 2. Other characteristics include an increase in protein synthesis and an increase in the size or number of intracellular organelles. 3. A cellular adaptation to increased workload results in hypertrophy, as exemplified by the increase in skeletal muscle mass associated with exercise and the enlargement of the left ventricle in hypertensive heart disease. B. Hyperplasia 1. Hyperplasia is an increase in the size of an organ or tissue caused by an increase in the number of cells. 2. It is exemplified by glandular proliferation in the breast during pregnancy. 3. In some cases, hyperplasia occurs together with hypertrophy. During pregnancy, uterine enlargement is caused by both hypertrophy and hyperplasia of the smooth muscle cells in the uterus. C. Aplasia 1. Aplasia is a failure of cell production. 2. During fetal development, aplasia results in agenesis, or absence of an organ due to failure of production. 3. Later in life, it can be caused by permanent loss of precursor cells in proliferative tissues, such as the bone marrow. D. Hypoplasia 1. Hypoplasia is a decrease in cell production that is less extreme than in aplasia. 2. It is seen in the partial lack of growth and maturation of gonadal structures in Turner syndrome and Klinefelter syndrome. E. Atrophy 1. Atrophy is a decrease in the size of an organ or tissue and results from a decrease in the mass of preexisting cells (Figure 1-1). -
The Soluble Form of HFE Protein Regulates Hephaestin Mrna Expression in the Duodenum Through an Endocytosis-Dependent Mechanism
CORE Metadata, citation and similar papers at core.ac.uk Provided by Elsevier - Publisher Connector Biochimica et Biophysica Acta 1842 (2014) 2298–2305 Contents lists available at ScienceDirect Biochimica et Biophysica Acta journal homepage: www.elsevier.com/locate/bbadis The soluble form of HFE protein regulates hephaestin mRNA expression in the duodenum through an endocytosis-dependent mechanism Bruno Silva a, Joana Ferreira a,VeraSantosa, Cilénia Baldaia b, Fátima Serejo b, Paula Faustino a,⁎ a Departamento de Genética Humana, Instituto Nacional de Saúde Dr. Ricardo Jorge, Lisboa, Portugal b Departamento de Gastroenterologia e Hepatologia, Hospital de Santa Maria, Centro Hospitalar Lisboa Norte, Lisboa, Portugal article info abstract Article history: Dietary iron absorption regulation is one of the key steps for the maintenance of the body iron homeostasis. Received 6 December 2013 HFE gene expression undergoes a complex post-transcriptional alternative splicing mechanism through which Received in revised form 25 June 2014 two alternative transcripts are originated and translated to a soluble HFE protein isoform (sHFE). The first pur- Accepted 15 July 2014 pose of this study was to determine if sHFE transcript levels respond to different iron conditions in duodenal Available online 27 July 2014 and macrophage cell models. In addition, we aimed to determine the functional effect of the sHFE protein on Keywords: the expression of iron metabolism-related genes in a duodenal cell model as well as, in vivo, in duodenum biopsy Alternative splicing samples. Iron metabolism Levels of sHFE transcripts were measured in HuTu-80, Caco-2, HT-29 and activated THP1 cells, after holo-Tf Enterocyte stimulus, and in total RNA from duodenum biopsies of functional dyspepsia patients. -
Genetical and Clinical Studies in Wilson's Disease
Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Medicine 246 Genetical and Clinical Studies in Wilson's Disease ERIK WALDENSTRÖM ACTA UNIVERSITATIS UPSALIENSIS ISSN 1651-6206 UPPSALA ISBN 978-91-554-6845-3 2007 urn:nbn:se:uu:diva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o my family At vide, hvad man ikke véd, er dog en slags alvidenhed Piet Hein List of publications This thesis is based on the following papers, which will be referred -
PATHOPHYSIOLOGY UNIT-1 .Basic Principles of Cell Injury And
B.PHARMACY2nd SEMESTER SUBJECT: PATHOPHYSIOLOGY UNIT-1 .Basic Principles of Cell Injury and Adaptation Cell Injury: Introduction • Cell injury is defined as a variety of stresses a cell encounters as a result of changes in its internal and external environment. • The cellular response to stress may vary and depends upon the following: – The type of cell and tissue involved. – Extent and type of cell injury. ETIOLOGY OF CELL INJURY: 1. Genetic causes • Developmental defects: Errors in morphogenesis • Cytogenetic (Karyotypic) defects: chromosomal abnormalities • Single-gene defects: Mendelian disorders • Multifactorial inheritance disorders. 2. Acquired causes • Hypoxia and ischaemia • Physical agents • Chemical agents and drugs • Microbial agents • Immunologic agents • Nutritional derangements • Aging • Psychogenic diseases • Iatrogenic factors • Idiopathic diseases. 2.1. Oxygen deprivation: HYPOXIA Ischemia (loss of blood supply). Inadequate oxygenation (cardio respiratory failure). Loss of oxygen carrying capacity of the blood (anemia or CO poisoning). 2.2. PHYSICAL AGENTS: Trauma Heat Cold Radiation Electric shock 2.3. CHEMICAL AGENTS AND DRUGS: Endogenous products: urea, glucose Exogenous agents Therapeutic drugs: hormones Nontherapeutic agents: lead or alcohol. 2.4. INFECTIOUS AGENTS: Viruses Rickettsiae Bacteria Fungi Parasites 2.5. Abnormal immunological reactions: The immune process is normally protective but in certain circumstances the reaction may become deranged. Hypersensitivity to various substances can lead to anaphylaxis or to more localized lesions such as asthma. In other circumstances the immune process may act against the body cells – autoimmunity. 2.6. Nutritional imbalances: Protein-calorie deficiencies are the most examples of nutrition deficiencies. Vitamins deficiency. Excess in nutrition are important causes of morbidity and mortality. Excess calories and diet rich in animal fat are now strongly implicated in the development of atherosclerosis. -
Sacrococcygeal Teratoma in the Perinatal Period
754 Postgrad Med J 2000;76:754–759 Postgrad Med J: first published as 10.1136/pgmj.76.902.754 on 1 December 2000. Downloaded from Sacrococcygeal teratoma in the perinatal period R Tuladhar, S K Patole, J S Whitehall Teratomas are formed when germ cell tumours tissues are less commonly identified.12 An ocu- arise from the embryonal compartment. The lar lens present as lentinoids (lens-like cells), as name is derived from the Greek word “teratos” well as a completely formed eye, have been which literally means “monster”. The ending found within sacrococcygeal teratomas.10 11 “-oma” denotes a neoplasm.1 Parizek et al reported a mature teratoma containing the lower half of a human body in Incidence one of fraternal twins.13 Sacrococcygeal teratoma is the most common congenital tumour in the neonate, reported in Size approximately 1/35 000 to 1/40 000 live Size of a sacrococcygeal teratoma (average 8 births.2 Approximately 80% of aVected infants cm, range 1 to 30 cm) does not predict its bio- are female—a 4:1 female to male preponder- logical behaviour.8 Altman et al have defined ance.2 the size of sacrococcygeal teratomas as follows: The first reported case was inscribed on a small, 2 to 5 cm diameter; moderate, 5 to 10 Chaldean cuneiform tablet dated approxi- cm diameter; large, > 10 cm diameter.14 mately 2000 BC.3 In the modern era, the first large series of infants and children with sacro- Site coccygeal teratomas was reported by Gross et The sacrococcygeal region is the most com- al in 1951.4 mon location. -
Somatic Events Modify Hypertrophic Cardiomyopathy Pathology and Link Hypertrophy to Arrhythmia
Somatic events modify hypertrophic cardiomyopathy pathology and link hypertrophy to arrhythmia Cordula M. Wolf*†, Ivan P. G. Moskowitz†‡§¶, Scott Arno‡, Dorothy M. Branco*, Christopher Semsarian‡§ʈ, Scott A. Bernstein**, Michael Peterson‡¶, Michael Maida‡, Gregory E. Morley**, Glenn Fishman**, Charles I. Berul*, Christine E. Seidman‡§††‡‡, and J. G. Seidman‡§†† Departments of *Cardiology and ¶Pathology, Children’s Hospital, Boston, MA 02115; ‡Department of Genetics, Harvard Medical School, Boston, MA 02115; §Howard Hughes Medical Institute, Boston, MA 02115; and **Department of Cardiology, New York University School of Medicine, New York, NY 10010 Contributed by Christine E. Seidman, October 19, 2005 Sarcomere protein gene mutations cause hypertrophic cardiomy- many HCM patients who succumb to ventricular arrhythmias all opathy (HCM), a disease with distinctive histopathology and in- of these risk factors are absent (11–13). creased susceptibility to cardiac arrhythmias and risk for sudden Increased myocardial fibrosis and abnormal myocyte archi- death. Myocyte disarray (disorganized cell–cell contact) and car- tecture are associated with arrhythmia vulnerability in many diac fibrosis, the prototypic but protean features of HCM histopa- cardiovascular diseases (14–16), and these parameters are hy- thology, are presumed triggers for ventricular arrhythmias that pothesized to also increase sudden death risk in HCM (12, 17). precipitate sudden death events. To assess relationships between In support of this suggestion, histopathological studies